Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21870291 | 0.99 | PLA2G2A (0.32) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL19575215 | 0.97 | PRKDC (0.32) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL15852157 | 0.95 | CYP1A2 (0.32) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL25006071 | 0.94 | — | — | |
| SCHEMBL15852159 | 0.93 | PLA2G2A (0.31) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL15852161 | 0.91 | PLA2G2A (0.35) | PLA2G2APLA2G4ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL24766864 | 0.90 | PRKDC (0.34) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL15852146 | 0.90 | KDM4E (0.32) | CA12CA1CA2CA9CYP1A1 | |
| SCHEMBL24472602 | 0.89 | ALOX5 (0.35) | PLA2G2APLA2G4ACYP1A2 | |
| SCHEMBL21906624 | 0.89 | ALOX5 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230020436-A1 | NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20210384430-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-12-09 | — | — | US | disclosed |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-20 | — | — | US | disclosed |
| US-10804474-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-13 | — | — | US | disclosed |
| US-20200111965-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
| US-20200111974-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200111965-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, ESR1 | CA12 3613/4885CA1 3201/4885CA2 4438/4885 |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, ESR1 | CA12 3613/4885CA1 3201/4885CA2 4438/4885 |
| US-20230020436-A1 | NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | MRPS22, RER1, EMC2 | CA12 2509/4885CA1 3024/4885CA2 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.